具代表性研究發表

搜尋類別: 關鍵字搜尋: 清除
年度 論文名稱
2024 Ya-Ling Chiang, Yu-Jen Chang, (Yun-Ru Chen, Ing-Shouh Hwang*, Evidence Supporting Enrichment of Dissolved Air Gases near Hydrophobic Macromolecules in Aqueous Solutions, Langmuir, vol. 41(1), 285-291, 2024
2024 Yesi Shi, Xueyan Zhen, Yiming Zhang, Yongjiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong*, Gang Liu*, Wei Chen*, Wei Tao* (*: Corresponding author, Chemically Modified Platforms for Better RNA Therapeutics, Chemical Reviews, vol. 124, 929-1033, 2024
2024 Muhammad Muzamil Khan, Yongjiang Li, Zhuoming Zhou, Abigale Ni, Qimanguli Saiding, Duotian Qin, Wei Tao*, Wei Chen*, Macrophage-modulating nanomedicine for cancer immunotherapy, Nanoscale, vol. 16, 7378-7386, 2024
2024 Yiming Zhang, Yesi Shi, Muhammad M Khan, Fan Xiao, Wei Chen, Wei Tao*, Ke Yao*, Na Kong*, Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases, Trends in Biotechnology (Cell Press), vol. In press, In press-In press, 2024
2024 Zhongshan He(#, Wei Chen(#)(*, Kuan Hu, #) Yaoyao Luo, Wanqin Zeng, Xi He, Tingting Li, Jiang Ouyang, Yongjiang Li, Lin Xie, Yiding Zhang, Qin Xu, Shuping Yang, Mengran Guo, Wei Zou, Yanfei Li, Lingjing Huang, Lu Chen, Xingcai Zhang, Qimanguli Saiding, Rui Wang, Ming-Rong Zhang, Na Kong, Tian Xie, Xiangrong Song(*, Wei Tao(*) (*: Co-corresponding author; #: Co-first author, equal contribution, Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment, Nature Nanotechnology, vol. doi.org/10.1038/s41565-024-01687-1, online-online, 2024
2024 Bin Zheng, Mengyi Li, Tiange Zhang, Bowen Li, Qiuya Li, Qimanguli Saiding, Wei Chen, Mingming Guo, Seyoung Koo*, Xiaoyuan Ji*, Wei Tao*, Functional modification of gut bacteria for disease diagnosis and treatment, Med (Cell Press), vol. 5, 863-885, 2024
2024 NCD Risk Factor Collaboration (NCD-RisC) (Majid Ezzati*, (Chen CJ, et al., Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults., LANCET, vol. 403(10431), 1027-1050, 2024
2024 NCD Risk Factor Collaboration (NCD-RisC) (Majid Ezzati*, (Chen CJ, et al., Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants., Lancet (London, England), vol. 404(10467), 2077-2093, 2024
2024 Kim GA, Lim YS*, Han S, Choi GH, Choi WM, Choi J, Sinn DH, Paik YH, Lee JH, Lee YB, Cho JY, Heo NY, Yuen MF, Wong VW, Chan SL, Yang HI, (Chen CJ, Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic Model., Annals of internal medicine, vol. 177(10), 1308-1318, 2024
2024 Ringborg U*, von Braun J, Celis J, Baumann M, Berns A, Eggermont A, Heard E, Heitor M, Chandy M, (Chen CJ, Costa A, De Lorenzo F, De Robertis EM, Dubee FC, Ernberg I, Gabriel M, Helland A, Henrique R, Jonsson B, Kallioniemi O, Korbel J, Krause M, Lowy DR, Michielin O, Nagy P, Oberst S, Paglia V, Parker MI, Ryan K, Sawyers CL, Schuz J, Silkaitis K, Solary E, Thomas D, Turkson P, Weiderpass E, Yang H, Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023., Molecular oncology, vol. 18(2), 245-279, 2024
2024 Chen YY*, Yang MH, Lai JZ, Chen JW, Wang YL, Wei ST, Hou SM, (Chen CJ, Wu HS*, Seroprevalence of Anti-SARS-CoV-2 Remained Extremely Low in Taiwan Until the Vaccination Program Was Implemented., Open forum infectious diseases, vol. 11(1), ofad614, 2024
2024 Jhuang JR, Lee CH, Chiang CJ, (Chen CJ, Lee WC*, Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan., Environment international, vol. 185, 108542, 2024
2024 Lin HC, Jeng WJ, Liu J, Pan MH, Lee MH, Batrla-Utermann R, Lu SN, Chen CF, Yang HI*, (Chen CJ, Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients., Alimentary pharmacology & therapeutics, vol. 59(8), 993-1002, 2024
2024 Oze I*, Ito H, Koyanagi YN, Abe SK, Rahman MS, Islam MR, Saito E, Gupta PC, Sawada N, Tamakoshi A, Shu XO, Sakata R, Malekzadeh R, Tsuji I, Kim J, Nagata C, You SL, Park SK, Yuan JM, Shin MH, Kweon SS, Pednekar MS, Tsugane S, Kimura T, Gao YT, Cai H, Pourshams A, Lu Y, Kanemura S, Wada K, Sugawara Y, (Chen CJ, Chen Y, Shin A, Wang R, Ahn YO, Shin MH, Ahsan H, Boffetta P, Chia KS, Qiao YL, Rothman N, Zheng W, Inoue M, Kang D, Matsuo K, Obesity is associated with biliary tract cancer mortality and incidence: A pooled analysis of 21 cohort studies in the Asia Cohort Consortium., International journal of cancer, vol. 154(7), 1174-1190, 2024
2024 Yang JJ, Wen W, Zahed H, Zheng W, Lan Q, Abe SK, Rahman MS, Islam MR, Saito E, Gupta PC, Tamakoshi A, Koh WP, Gao YT, Sakata R, Tsuji I, Malekzadeh R, Sugawara Y, Kim J, Ito H, Nagata C, You SL, Park SK, Yuan JM, Shin MH, Kweon SS, Yi SW, Pednekar MS, Kimura T, Cai H, Lu Y, Etemadi A, Kanemura S, Wada K, (Chen CJ, Shin A, Wang R, Ahn YO, Shin MH, Ohrr H, Sheikh M, Blechter B, Ahsan H, Boffetta P, Chia KS, Matsuo K, Qiao YL, Rothman N, Inoue M, Kang D, Robbins HA, Shu XO*, Lung Cancer Risk Prediction Models for Asian Ever-Smokers., Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 19(3), 451-464, 2024
2024 Chang GC, Chiu CH, Yu CJ, Chang YC, Chang YH, Hsu KH, Wu YC, Chen CY, Hsu HH, Wu MT, Yang CT, Chong IW, Lin YC, Hsia TC, Lin MC, Su WC, Lin CB, Lee KY, Wei YF, Lan GY, Chan WP, Wang KL, Wu MH, Tsai HH, Chian CF, Lai RS, Shih JY, Wang CL, Hsu JS, Chen KC, Chen CK, Hsia JY, Peng CK, Tang EK, Hsu CL, Chou TY, Shen WC, Tsai YH, Tsai CM, Chen YM, Lee YC, Chen HY, Yu SL, (Chen CJ, Wan YL, Hsiung CA, Yang PC*, Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study., The Lancet. Respiratory medicine, vol. 12(2), 141-152, 2024
2024 Downward GS*, Hystad P, Tasmin S, Abe SK, Saito E, Rahman MS, Islam MR, Gupta PC, Sawada N, Malekzadeh R, You SL, Ahsan H, Park SK, Pednekar MS, Tsugane S, Etemadi A, (Chen CJ, Shin A, Chen Y, Boffetta P, Chia KS, Matsuo K, Qiao YL, Rothman N, Zheng W, Inoue M, Kang D, Lan Q, Vermeulen RCH, Long-term exposure to particulate matter and all-cause and cause-specific mortality in an analysis of multiple Asian cohorts., Environment international, vol. 189, 108803, 2024
2024 Hsu WL, Tao J, Fu S, Yu KJ, Simon J, Chen TC, (Chen CJ, Goldstein AM, Yu K, Hildesheim A, Waterboer T*, Wang CP*, Liu Z*, Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families., International journal of cancer, vol. 155(8), 1400-1408, 2024
2024 Chang SH, Su TH*, Ling ZM, Lee MH, Liu CJ, Chen PJ, Yang HC, Liu CH, Chen CL, Tseng TC, Chen CH, Lee HS, (Chen CJ, Kao JH*, Fibrosis-4 index stratifies risks of hepatocellular carcinoma in patients with chronic hepatitis C., Journal of the Formosan Medical Association = Taiwan yi zhi, vol. 123(11), 1154-1160, 2024
2024 Lu TY, Wu CD, Huang YT, Chen YC, (Chen CJ, Yang HI, Pan WC*, Exposure to PM(2.5) Metal Constituents and Liver Cancer Risk in REVEAL-HBV., Journal of epidemiology, vol. 34(2), 87-93, 2024
2024 Lee MH*, Chen YT, Huang YH, Lu SN, Yang TH, Huang JF, Yin SC, Yeh ML, Huang CF, Dai CY, Chuang WL, Yu ML, Yang HI, Chen HY, (Chen CJ, Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC., Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 22(6), 1275-1285.e2, 2024
2024 Paragomi P, Zhang Z, Abe SK, Islam MR, Rahman MS, Saito E, Shu XO, Dabo B, Pham YT, Chen Y, Gao YT, Koh WP, Sawada N, Malekzadeh R, Sakata R, Hozawa A, Kim J, Kanemura S, Nagata C, You SL, Ito H, Park SK, Yuan JM, Pan WH, Wen W, Wang R, Cai H, Tsugane S, Pourshams A, Sugawara Y, Wada K, (Chen CJ, Oze I, Shin A, Ahsan H, Boffetta P, Chia KS, Matsuo K, Qiao YL, Rothman N, Zheng W, Inoue M, Kang D, Luu HN*, Body Mass Index and Risk of Colorectal Cancer Incidence and Mortality in Asia., JAMA network open, vol. 7(8), e2429494, 2024
2024 Liu KL, Hsu WL*, Bu W, Yu KJ, Wang CP, Chien YC, Chen TC, (Chen CJ, Hildesheim A, Middeldorp JM, Waterboer T, Cohen JI, Coghill AE, Liu Z, Association Between Antibodies That Bind Epstein-Barr Virus (EBV) gp350 and gH/gL and Shedding of EBV in Saliva From Nasopharyngeal Carcinoma Multiplex Family Members in Taiwan., Open forum infectious diseases, vol. 11(9), ofae464, 2024
2024 Polaris Observatory Collaborators (D. Razavi-Shearer*, (Chen CJ, et al., Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories., Journal of hepatology, vol. 80(2), 232-242, 2024
2024 Chen CL*, Yang WS, Yang HI, Chen CF, Wang LY, Lu SN, Kao JH, Chen PJ, (Chen CJ, Plasma Adiponectin Levels in Relation to Chronic Hepatitis B Infection Progression to Liver Cancer Milestones: A Prospective Study, Liver Cancer, vol. 10(6), 1-17, 2024
2024 Chen, Y.-L.*, Hsieh, J.-W. A., Kuo, S.-C., Kao, C.-T., Tung, C.-C., Yu, J.-H., 「Chang, T.-H.」, Ku, C., Xie, J., Zhang, D., Li, Q., Lin, Y.-C. J.*, Merit of integrating in situ transcriptomics and anatomical information for cell annotation and lineage construction in single-cell analyses of Populus, Genome Biol., vol. 25, 85, 2024
2023 Zani F, Blagih J, Gruber T, Buck MD, Jones N, Hennequart M, Newell CL, Pilley SE, Soro-Barrio P, Kelly G, Legrave NM, Cheung EC, Gilmore IS, Gould AP, Garcia-Caceres C, Vousden KH, The dietary sweetener sucralose is a negative modulator of T cell-mediated responses., Nature, vol. 615(7953), 705-711, 2023
2023 Hennequart M, Pilley SE, Labuschagne CF, Coomes J, Mervant L, Driscoll PC, Legrave NM, Lee Y, Kreuzaler P, Macintyre B, Panina Y, Blagih J, Stevenson D, Strathdee D, Schneider-Luftman D, Gronroos E, Cheung EC, Yuneva M, Swanton C, Vousden KH, ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis., Cell reports, vol. 42(6), 112562, 2023
2023 Che TF, Chiu CH, Wu YC, Chen JY, Chou TY, Cheng YC, Chiang CL, Huang CS, Tuang IS, Ho YH, Hong JH, Huang YJ, Ho HL, (Chang YC)*, Proliferative ability of circulating tumor cells is a prognostic factor in Early-Stage lung adenocarcinoma., Lung Cancer (Amsterdam, Netherlands), vol. 178, 198-205, 2023
2023 Yeh PY, Chen JY, Shen MY, Che TF, Lim SC, Wang J, Tsai WS, Frank CW, Huang CJ, (Chang YC)*, Liposome-tethered supported lipid bilayer platform for capture and release of heterogeneous populations of circulating tumor cells., Journal of Materials Chemistry. B, vol. 11(34), 8159-8169, 2023